Literature DB >> 22674797

The dog as a possible animal model for human non-Hodgkin lymphoma: a review.

Laura Marconato1, Maria Elena Gelain, Stefano Comazzi.   

Abstract

Lymphoma represents the most frequent hematopoietic cancer in dogs, and it shows significant overlap with the human disease. Several environmental factors have been associated with canine lymphoma, suggesting that they may contribute to lymphomagenesis. Canine lymphoma often presents in advanced stage (III-V) at diagnosis and, most commonly, has an aggressive clinical course requiring prompt treatment, which relies on the use of polychemotherapy. In this review, we will summarize the state-of-the-art of canine lymphoma epidemiology, pathobiology, diagnostic work-up and therapy, and will highlight the links to the corresponding human disease, providing evidence for the use of dog as an animal model of spontaneous disease.
Copyright © 2012 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2012        PMID: 22674797     DOI: 10.1002/hon.2017

Source DB:  PubMed          Journal:  Hematol Oncol        ISSN: 0278-0232            Impact factor:   5.271


  50 in total

1.  Feasibility and Safety of RNA-transfected CD20-specific Chimeric Antigen Receptor T Cells in Dogs with Spontaneous B Cell Lymphoma.

Authors:  M Kazim Panjwani; Jenessa B Smith; Keith Schutsky; Josephine Gnanandarajah; Colleen M O'Connor; Daniel J Powell; Nicola J Mason
Journal:  Mol Ther       Date:  2016-07-12       Impact factor: 11.454

Review 2.  Canine lymphoma as a comparative model for human non-Hodgkin lymphoma: recent progress and applications.

Authors:  Daisuke Ito; Aric M Frantz; Jaime F Modiano
Journal:  Vet Immunol Immunopathol       Date:  2014-02-24       Impact factor: 2.046

3.  VH1-44 gene usage defines a subset of canine B-cell lymphomas associated with better patient survival.

Authors:  Hsiao-Wei Chen; George W Small; Alison Motsinger-Reif; Steven E Suter; Kristy L Richards
Journal:  Vet Immunol Immunopathol       Date:  2013-11-21       Impact factor: 2.046

Review 4.  Development and Significance of Mouse Models in Lymphoma Research.

Authors:  Jordan N Noble; Anjali Mishra
Journal:  Curr Hematol Malig Rep       Date:  2019-04       Impact factor: 3.952

5.  Comparative Exposure Assessment Using Silicone Passive Samplers Indicates That Domestic Dogs Are Sentinels To Support Human Health Research.

Authors:  Catherine F Wise; Stephanie C Hammel; Nicholas Herkert; Jun Ma; Alison Motsinger-Reif; Heather M Stapleton; Matthew Breen
Journal:  Environ Sci Technol       Date:  2020-05-28       Impact factor: 9.028

6.  Antitumor Activity of Betulinic Acid and Betulin in Canine Cancer Cell Lines.

Authors:  Jing Zhao; Rongfang Li; Aleksandra Pawlak; Marta Henklewska; Angelika Sysak; Lixin Wen; Jin-E Yi; Bożena Obmińska-Mrukowicz
Journal:  In Vivo       Date:  2018 Sep-Oct       Impact factor: 2.155

7.  Safety and efficacy of a genetic vaccine targeting telomerase plus chemotherapy for the therapy of canine B-cell lymphoma.

Authors:  Alessandra Gavazza; George Lubas; Arthur Fridman; Daniela Peruzzi; Joseph A Impellizeri; Laura Luberto; Emanuele Marra; Giuseppe Roscilli; Gennaro Ciliberto; Luigi Aurisicchio
Journal:  Hum Gene Ther       Date:  2013-08       Impact factor: 5.695

Review 8.  Comparative oncology: what dogs and other species can teach us about humans with cancer.

Authors:  Joshua D Schiffman; Matthew Breen
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-07-19       Impact factor: 6.237

9.  Constitutive activation of alternative nuclear factor kappa B pathway in canine diffuse large B-cell lymphoma contributes to tumor cell survival and is a target of new adjuvant therapies.

Authors:  Davis M Seelig; Daisuke Ito; Colleen L Forster; Una A Yoon; Matthew Breen; Linda J Burns; Veronika Bachanova; Kerstin Lindblad-Toh; Timothy D O'Brien; Stephen C Schmechel; Anthony E Rizzardi; Jaime F Modiano; Michael A Linden
Journal:  Leuk Lymphoma       Date:  2016-12-08

10.  Generation of a canine anti-EGFR (ErbB-1) antibody for passive immunotherapy in dog cancer patients.

Authors:  Josef Singer; Judit Fazekas; Wei Wang; Marlene Weichselbaumer; Miroslawa Matz; Alexander Mader; Willibald Steinfellner; Sarah Meitz; Diana Mechtcheriakova; Yuri Sobanov; Michael Willmann; Thomas Stockner; Edzard Spillner; Renate Kunert; Erika Jensen-Jarolim
Journal:  Mol Cancer Ther       Date:  2014-04-22       Impact factor: 6.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.